Antihypertensive Drugs Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025– Increasing irregular and unhealthy lifestyles are leading to hypertension and therefore, majorly driving the market growth.
Antihypertensive Drugs Market is valued at USD 22.56 Billion in 2018 and expected to reach USD 26.82 Billion by 2025 with a CAGR of 2.5% over the forecast period.
Scope of Antihypertensive Drugs Market Report–
Antihypertensives are a class of drugs that are used to treat high blood pressure that is hypertension. The hypertensive drugs seek to prevent the difficulties of hypertension as myocardial infarction (heart attack) and strokes. The anti-hypertension drugs are used for leveling or reducing blood pressure. Hypertension is a chronic condition, in which the blood pressure is elevated abnormally systolic as well as diastolic. This is major risk factor for causing cardiovascular, renal or endocrine disorders. The drugs comprise numerous classes of compounds with the therapeutic intention of preventing, controlling, or treating hypertension. The ultimate goal of antihypertensive drugs is to reduce cardiovascular morbidity and mortality. These are frequently used by patients and may influence conduct of anesthesia. These drugs have diverse indications, both cardiac and non-cardiac. Comparatively limited drug classes are used to treat hypertension, the newest among them are direct renin inhibitors. The renin–angiotensin system is targeted at different points by many of the commonly used antihypertensive drugs.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=162626&RequestType=Sample
Antihypertensive Drugs market report is segmented on the basis of type, application and region & country level. Based upon type, antihypertensive drugs market is segmented into ARB, CCB and others. Based on application, antihypertensive drugs market is segmented into hypertension, PAH and others.
The regions covered in this antihypertensive drugs market report are North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. On the basis of country level, the market of antihypertensive drugs market is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Key Players for Antihypertensive Drugs Market Report–
Some major key players for antihypertensive drugs market are Novartis, Pfizer, Johnson & Johnson, Sanofi, Lupin, Ranbaxy Laboratories, Merck, Astra Zeneca, Daiichi Sankyo, Takeda, Actelion, United Therapeutics, JW Pharmaceutical, Gilead, CJ Healthcare, Bayer, Boryung Pharmaceutical, Cipla and others.
Cipla Got USFDA Nod for Pulmonary Arterial Hypertension Drug (PAH).
On April 30th, 2019; The major drug leader company Cipla received final approval from the United States food and drug administration (USFDA) for Ambrisentan tablets, specified for the treatment of pulmonary arterial hypertension (PAH). Cipla’s Ambrisentan tablets 5 mg and 10 mg is AB-rated generic therapeutic equivalent version of Gilead Sciences Inc.’s Letairis, the Mumbai-based company. Ambrisentan tablet is an endothelin receptor contender directed for the treatment of pulmonary arterial hypertension to improve exercise ability and delay clinical worsening. It is used to treat high blood pressure in the lungs. This medication blocks the effects of endothelin-1, helping to decrease the blood pressure in the lungs, slow the worsening of symptoms, and improve patient’s ability to exercise. The dosage is based on patient’s medical condition, response to treatment, and other medications. It is approved in Europe, Canada and the United States for use as a single agent. Studies establishing the efficacy of Ambrisentan included patients with idiopathic as well as inborn pulmonary arterial hypertension and with pulmonary arterial hypertension associated with connective tissue diseases. As an endothelin receptor, Ambrisentan prevents endogenous endothelin peptide from compressing the muscles in blood vessels, allowing them to relax and permit a reduction in blood pressure.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=162626&RequestType=Methodology
Antihypertensive Drugs Market Dynamics–
Growing awareness about hypertension with increasing predominance, fix dose blending therapies and increased epidemic proportion of hypertension are the major factors driving the growth of global antihypertensive drugs market. In addition to this, irregular lifestyles with food habits, changes in lifestyle, aging regardless of demography and supplemented stress level are also supplementing the growth of antihypertensive drugs market. However, side effects of drugs such as; cough, diarrhea, nervousness, constipation, dizziness and weakness and increased risk of genericization may hamper the growth of market.
Moreover, increasing research and development for the novel pipeline drugs are expected more to fuel antihypertensive market in the forthcoming period. Pulmonary hypertensive practices offering training programs for people, high predominance of incessant illness, initiatives taken by government and the growing commonness of hypertension in youth population are also supporting the revenue opportunities for the antihypertensive drugs market.
Antihypertensive Drugs Market Regional Analysis-
The antihypertensive drugs market by region is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America is expected to capture the largest market share owing to the high prevalence of hypertension related to renal and cardiovascular disorders in this region. Running drives by non-government and government organizations for spreading awareness among people are mostly bottling revenue generation opportunities in North America. As per the American Heart Association, under the updated guideline, more people will be diagnosed with hypertension, nearly half of American adults (46%), up from 32% under the previous definition.
Europe is expected to capture the second position due to the prevalence of cardiovascular diseases, improper diet habits, increasing obesity in children as well as in adults and high prevalence of hypertension that leads to death or disabilities in people. Asia-Pacific region will witness high growth in the antihypertensive drugs market owing to the high incidences of cardiovascular diseases, government initiatives taken for healthcare sector and high population pool.
Key Benefits for Antihypertensive Drugs Market Report–
Antihypertensive Drugs Market report covers in-depth historical and forecast analysis.
Antihypertensive Drugs Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
Antihypertensive Drugs Market report helps to identify opportunities in marketplace.
Antihypertensive Drugs Market report covers extensive analysis of emerging trends and competitive landscape.
Buy this Report @ https://brandessenceresearch.biz/Buy/Create/162626/Buy/SingleUser
Antihypertensive Drugs Market Segmentation:
By Regional & Country Analysis:
Middle East and Africa
Rest of Middle East and Africa
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Antihypertensive Drugs Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Antihypertensive Drugs Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Antihypertensive Drugs Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter – Global Antihypertensive Drugs Market Overview: Quantitative Analysis
3.1. Global Antihypertensive Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Antihypertensive Drugs Market Revenue Market Share (%), 2014- 2025
3.3. Global Antihypertensive Drugs Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Antihypertensive Drugs Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Antihypertensive Drugs Market Analysis: Segmentation By Type
5. Chapter – Global Antihypertensive Drugs Market Analysis: Segmentation By Application
6. Chapter – Global Antihypertensive Drugs Market Analysis: By Manufacturer
6.1. Global Antihypertensive Drugs Market Revenue (USD Million), by Manufacturer, 2014 – 2025
6.2. Global Antihypertensive Drugs Market Share (%), by Manufacturer, 2018
6.3. Global Antihypertensive Drugs Market Sales (Number of Units), by Manufacturer, 2014 – 2025
6.4. Global Antihypertensive Drugs Market Share (%), by Manufacturer, 2018
6.5. Global Antihypertensive Drugs Market Price (USD/Unit), by Manufacturer, 2014 – 2025
6.6. Global Antihypertensive Drugs Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
6.7. Merger & Acquisition
6.8. Collaborations and Partnership
6.9. New Product Launch
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org